An evaluation of the design of clinical trials conducted for rheumatoid arthritis, 2009-2022

Previous PostModified Delphi research to seek consensus on dRTA disease model, treatment and management
Next PostA review and evaluation of successfully reimbursed orphan and non-orphan drugs in Ireland